Compare ALXO & GORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALXO | GORO |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.3M | 250.9M |
| IPO Year | 2020 | 2010 |
| Metric | ALXO | GORO |
|---|---|---|
| Price | $2.18 | $1.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $3.42 | $1.75 |
| AVG Volume (30 Days) | 1.0M | ★ 3.3M |
| Earning Date | 06-01-2026 | 04-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $65,726,000.00 |
| Revenue This Year | N/A | $9.04 |
| Revenue Next Year | N/A | $93.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $0.34 |
| 52 Week High | $2.66 | $1.87 |
| Indicator | ALXO | GORO |
|---|---|---|
| Relative Strength Index (RSI) | 52.41 | 51.86 |
| Support Level | $1.41 | $0.79 |
| Resistance Level | $2.27 | $1.81 |
| Average True Range (ATR) | 0.27 | 0.12 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 23.08 | 38.90 |
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.